The combined effects of semaglutide and an existing heart condition could potentially increase the risk of AFib
No human RCT has confirmed an optimal injectable schedule for cosmetic or wound-healing endpoints
Psychoneuroendocrinology (2004) 29(10):132634
Dentistry-related tidbits: This medication may cause changes in taste
7 biggest news story of 2025: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), in widespread use to treat diabetes and obesity, have also demonstrated off-label benefits for a multitude of conditions, including cardiovascular disease, hypertension, Parkinsons, Alzheimers and some addictive disorders
Its effectiveness rate exceeds 99%, meaning fewer than 1 in 100 women using Mirena will become pregnant within a year